FDA Approved: PROCRIT — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

FDA approved a supplemental application for PROCRIT (epoetin alfa) from Janssen, resulting in labeling changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Associated with Cancer Chemotherapy
• Anemia Associated with Chronic Kidney Disease
• Anemia Associated with HIV Infection

Drugs mentioned

• PROCRIT (ERYTHROPOIETIN)

Snippet

SUPPL AP for PROCRIT (ERYTHROPOIETIN)